Guest: Dr. Myla Lai-Goldman, Co-founder, CEO & President, GeneCentric Therapeutics, Inc., Research Triangle Park, NC
Topics: Dr. Lai-Goldman’s career in science, medicine, and business; pathology; GeneCentric Therapeutics’ Cancer Subtype Platform, precision medicine, cancer drug development

Dr. Myla Lai-Goldman

GeneCentric Therapeutics, Inc.

GeneCentric’s management team

Hatteras Venture Partners

LabCorp

Click to Download: Radio In Vivo November 1, 2017